← All Optimizerx CORP filings

Optimizerx CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
OPRX
Optimizerx CORP
DEF: OptimizeRx Sets Annual Meeting Agenda, Proposes Equity Plan Changes
OptimizeRx Corporation has issued its proxy statement detailing the agenda for its upcoming Annual Meeting of Shareholders on June 9, 2026, including proposals to amend its 2021 Equity Incentive Plan.
NASDAQ
OPRX
Optimizerx CORP
DEF: OptimizeRx Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
OptimizeRx Corporation will hold its annual stockholders meeting virtually on June 11, 2025, to vote on director elections, executive compensation, and auditor ratification.
NASDAQ
OPRX
Optimizerx CORP
DEFA14A: OptimizeRx Faces Director Nomination Challenge from Whetstone Capital Advisors Ahead of 2025 Annual Meeting
OptimizeRx has received notice from Whetstone Capital Advisors regarding their intention to nominate two candidates for election to the Board of Directors at the upcoming 2025 Annual Meeting.
NASDAQ
OPRX
Optimizerx CORP
DEF 14A: OptimizeRx Seeks Stockholder Approval for Equity Incentive Plan Expansion, Director Elections and Auditor Ratification Highlight Annual Meeting Agenda
OptimizeRx Corporation is holding its annual virtual meeting on June 5, 2024, to vote on director elections, executive compensation, an equity incentive plan amendment, and auditor ratification.